TradingView
EPSMomentum
Nov 30, 2020 3:43 PM

$ARWR with a neutral outlook following its earning release 

Arrowhead Pharmaceuticals, Inc.NASDAQ

Description

ARWR released its earnings with a negative under reaction following its announcement with the PEAD projecting a neutral outlook and placing the stock in Drift D

If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.

More